On Nov 9, 2021 3Bar Biologics closed a Seed round and raised $250,000 from S2G Ventures, featuring lead investors S2G Ventures. About the company: 3Bar […]
Venture Round – Truveta
On Nov 9, 2021 Truveta closed a Venture – Series Unknown round and raised $100,000,000 from investors, featuring lead investors . About the company: Truveta […]
Series B – Arbor Biotechnologies
On Nov 9, 2021 Arbor Biotechnologies closed a Series B round and raised $215,000,000 from Ally Bridge Group, ARCH Venture Partners, ArrowMark Partners, Deep Track […]
Series E – Color
On Nov 9, 2021 Color closed a Series E round and raised $100,000,000 from Emerson Collective, General Catalyst, Kindred Ventures, T. Rowe Price, Viking Global […]
Grant – DNA Script
On Nov 9, 2021 DNA Script closed a Grant round and raised $2,200,000 from National Human Genome Research Institute, featuring lead investors National Human Genome […]
Venture Round – Truveta
On Nov 9, 2021 Truveta closed a Venture – Series Unknown round and raised $100,000,000 from investors, featuring lead investors . About the company: Truveta […]
Revision Skincare acquired by Gryphon Investors
Nov 8, 2021 Gryphon Investors has entered into an agreement to acquire Revision Skincare . Gryphon Investors based at San Francisco, California, United States. “Partners […]
Series B – GeneCentric Therapeutics
On Nov 8, 2021 GeneCentric Therapeutics closed a Series B round and raised $7,500,000 from Alexandria Venture Investments, Hatteras Venture Partners, IAG Capital Partners, LabCorp, […]
Grant – Vasomune
On Nov 8, 2021 Vasomune closed a Grant round and raised $6,400,000 from U.S. Department of Defense, featuring lead investors U.S. Department of Defense. About […]
Post-IPO Debt – Amyris
On Nov 8, 2021 Amyris closed a Post-IPO Debt round and raised $400,000,000 from investors, featuring lead investors . About the company: Amyris is located […]
